Banks, Private Debt Prep €3.6 Billion on GTCR Zentiva Deal (1)

Wall Street banks including Goldman Sachs Group Inc. and private credit lenders are lining up around €3.6 billion ($4.2 billion) of debt financing to back buyout firm GTCR’s acquisition of generic drugmaker Zentiva Group AS, according to people with knowledge of the matter.

Others expected to have a lead role in the jumbo package include JPMorgan Chase & Co., Morgan Stanley, and Barclays Plc, said the people, who asked not to be identified because the talks are private. Chicago-based GTCR agreed to buy Zentiva in a $4.8 billion deal announced on Thursday. Other banks on ...